Quick Takeaways
- PERCEPTIVE ADVISORS LLC filed SCHEDULE 13G for Traws Pharma, Inc. Common Stock, par value $0.01 per share (TRAW).
- Disclosed ownership: 9.9%.
- Date of event: 31 Dec 2024.
PERCEPTIVE ADVISORS LLC - 31 Dec 2024 SCHEDULE 13G Report for Traws Pharma, Inc. Common Stock, par value $0.01 per share (TRAW)
- Filing Manager
- PERCEPTIVE ADVISORS LLC
- Reporting Manager
- Perceptive Advisors LLC
- Symbol
- TRAW
- Shares outstanding
- 3,904,596 shares
- Disclosed Ownership
- 386,555 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G
- Filing time
- 08 Jan 2025, 21:28:02 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 15 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"PERCEPTIVE ADVISORS LLC disclosed 9.9% ownership in Traws Pharma, Inc. Common Stock, par value $0.01 per share (TRAW) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 08 Jan 2025, 21:28.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Perceptive Advisors LLC | 9.9% | 386,555 | 0 | 386,555 | /s/ Joseph Edelman | Managing Member | |
| Joseph Edelman | 9.9% | 386,555 | 0 | 386,555 | /s/ Joseph Edelman | Managing Member | |
| Perceptive Life Sciences Master Fund, Ltd | 9.9% | 386,555 | 0 | 386,555 | Perceptive Advisors LLC | Joseph Edelman Managing Member |